adenoidal hypertrophy
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Meets the diagnostic criteria and traditional Chinese medicine syndrome differentiation criteria for adenoid hypertrophy; (2) Select children aged 3-14 years old, regardless of gender; (3) Those who have obtained informed consent from their legal guardians and are able to cooperate with treatment.
Exclusion criteria
Exclusion criteria: (1) Not meeting inclusion criteria (2) Individuals who have received other medications or surgical treatments in the past 2 weeks or have participated in clinical trials of other related medications. (3) Individuals with severe deviation of the nasal septum and respiratory distress caused by obesity, nasal polyps, upper airway neuromuscular tension, laryngeal and tracheal diseases, etc; (4) Individuals with severe liver and kidney diseases, cardiovascular diseases, endocrine disorders, hematological disorders, and neurological disorders; (5) Individuals who are known to have allergies to the drugs in this prescription.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Thickness of adenoids/width of nasopharyngeal cavity(A/N); | — |
Secondary
| Measure | Time frame |
|---|---|
| Traditional Chinese Medicine Syndrome Points;Disease specific quality of for children with obstructive sleep apnea 18 items survey(OSA-18);Apnea-HypopneaIndex(AHI); | — |
Countries
China
Contacts
Shanghai Municipal Hospital of Traditional Chinese Medicine